Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries.

ESMO real world data and digital oncology·2026

Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation.

Bone marrow transplantation·2026

Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCT.

Bone marrow transplantation·2025

Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.

Bone marrow transplantation·2025

Effects of Lack of Access to Immunotherapy Medications on Survival of Lung Cancer Patients.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomas.

European journal of haematology·2023

Hyperacute Graft-Versus-Host Disease.

Bone marrow transplantation·2026

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

Bone marrow transplantation·2026

GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party.

Bone marrow transplantation·2026

BEAM versus EAM, FEAM, BeEAM, and TEAM: exploring conditioning strategies in autologous stem cell transplantation for Hodgkin lymphoma a retrospective study of the LWP of EBMT.

Bone marrow transplantation·2026

Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP.

Bone marrow transplantation·2026

ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202.

Bone marrow transplantation·2026

Co-Administration of Mavacamten and Tacrolimus in a Renal Transplant Recipient With Obstructive Hypertrophic Cardiomyopathy.

JACC. Case reports·2026

A Review of the Vascular Pathophysiology of Migraine: Should We Consider Statins as a Treatment Option?

Current vascular pharmacology·2026

Multi‑target mechanisms of paeoniflorin in inflammatory regulation: A network pharmacology (Review).

International journal of molecular medicine·2026

Evaluation of the genotoxic potential of two rice herbicides, cyhalofop-butyl and quinclorac, in Drosophila melanogaster.

PeerJ·2026

Tyr-Mpa Proximity-Induced Atypical tert-Butyl Intramolecular Migration in Desmopressin: Mechanistic Elucidation of a Site-Selective Impurity and Its Suppression Strategy.

ACS omega·2026

Traditional Chinese botanical medicines and plant-derived bioactive compounds in amyotrophic lateral sclerosis: mechanistic evidence, translational challenges, and therapeutic opportunities.

Frontiers in pharmacology·2026

Related Experiment Videos

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

Related Concept Videos

Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries.

Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation.

Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCT.

Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.

Effects of Lack of Access to Immunotherapy Medications on Survival of Lung Cancer Patients.

Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomas.

Hyperacute Graft-Versus-Host Disease.

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party.

BEAM versus EAM, FEAM, BeEAM, and TEAM: exploring conditioning strategies in autologous stem cell transplantation for Hodgkin lymphoma a retrospective study of the LWP of EBMT.

Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP.

ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202.

Co-Administration of Mavacamten and Tacrolimus in a Renal Transplant Recipient With Obstructive Hypertrophic Cardiomyopathy.

A Review of the Vascular Pathophysiology of Migraine: Should We Consider Statins as a Treatment Option?

Multi‑target mechanisms of paeoniflorin in inflammatory regulation: A network pharmacology (Review).

Evaluation of the genotoxic potential of two rice herbicides, cyhalofop-butyl and quinclorac, in Drosophila melanogaster.

Tyr-Mpa Proximity-Induced Atypical tert-Butyl Intramolecular Migration in Desmopressin: Mechanistic Elucidation of a Site-Selective Impurity and Its Suppression Strategy.

Traditional Chinese botanical medicines and plant-derived bioactive compounds in amyotrophic lateral sclerosis: mechanistic evidence, translational challenges, and therapeutic opportunities.

Related Experiment Videos

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

Related Concept Videos

Related Articles